Arti Medical Research Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.81 Cr
as on 07-07-2024
- Revenue -11.36%
(FY 2023)
- Profit -54.63%
(FY 2023)
- Ebitda -40.50%
(FY 2023)
- Net Worth 18.38%
(FY 2023)
- Total Assets 22.41%
(FY 2023)
About Arti Medical Research Foundation
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.81 Cr.
Anushka Shaw, Adarsh Shaw, Arati Shaw, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300WB2012NPL180138
- Company No.
180138
- Company Classification
Private Not For Profit Company
- Incorporation Date
12 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arti Medical Research Foundation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anushka Shaw  | Director | 30-Sep-2022 | Current |
| Adarsh Shaw | Director | 30-Sep-2022 | Current |
| Arati Shaw | Director | 12-Apr-2012 | Current |
| Ajay Shaw | Director | 15-Dec-2012 | Current |
Financial Performance of Arti Medical Research Foundation.
Arti Medical Research Foundation, for the financial year ended 2023, experienced significant reduction in revenue, with a 11.36% decrease. The company also saw a substantial fall in profitability, with a 54.63% decrease in profit. The company's net worth Soared by an impressive increase of 18.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arti Medical Research Foundation?
In 2023, Arti Medical Research Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bryony Constructions Private LimitedActive 10 years 5 monthsArati Shaw and Ajay Shaw are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 26 Sep 2023 | ₹1.24 M | Open |
Axis Bank Limited Creation Date: 26 Sep 2023 | ₹1.18 M | Open |
Hdfc Bank Limited Creation Date: 31 Jul 2023 | ₹0.61 M | Open |
How Many Employees Work at Arti Medical Research Foundation?
Unlock and access historical data on people associated with Arti Medical Research Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arti Medical Research Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arti Medical Research Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
